Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnel is a dietary supplement developed by Omnifarma, primarily indicated for the prevention and treatment of magnesium and vitamin B6 deficiencies. It contains a combination of magnesium (typically as magnesium citrate) and pyridoxine hydrochloride (Vitamin B6). Magnesium is a vital intracellular cation involved in over 300 metabolic processes, including ATP production, muscle contraction, and neuronal excitability. Pyridoxine acts as a coenzyme in the metabolism of amino acids and neurotransmitters and is known to synergistically enhance the intestinal absorption and cellular retention of magnesium. This combination is frequently used to alleviate symptoms of deficiency such as irritability, sleep disturbances, muscle cramps, and fatigue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium + pyridoxine (OMNIFARMA).